ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

Nicoletta Colombo; Carien Creutzberg; Frederic Amant; Tjalling Bosse; Antonio González-Martín; Jonathan Ledermann; Christian Marth; Remi Nout; Denis Querleu; Mansoor Raza Mirza; Cristiana Sessa; ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group

doi:10.1016/j.radonc.2015.11.013

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

Radiother Oncol. 2015 Dec;117(3):559-81. doi: 10.1016/j.radonc.2015.11.013. Epub 2015 Dec 9.

Collaborators

ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group:
Miguel Abal, Ozden Altundag, Frederic Amant, Susana Banerjee, Tjalling Bosse, Antonio Casado, Luis Chiva de Agustín, David Cibula, Nicoletta Colombo, Carien Creutzberg, Josep-María del Campo, Günter Emons, Frédéric Goffin, Antonio González-Martín, Stefano Greggi, Christine Haie-Meder, Dionyssios Katsaros, Vesna Kesic, Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matias-Guiu, Philippe Morice, Hans W Nijman, Remi Nout, Melanie Powell, Denis Querleu, Mansoor R Mirza, Nick Reed, Alexandros Rodolakis, Helga Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke Westermann, Alain G Zeimet

Affiliations

¹ Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy. Electronic address: [email protected].
² Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium; Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
⁴ Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
⁵ Medical Oncology Department, GEICO, Madrid, Spain; MD Anderson Cancer Center, Madrid, Spain.
⁶ Department of Oncology and Cancer Trials, UCL Cancer Institute, London, United Kingdom.
⁷ Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
⁸ Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
⁹ Department of Surgery, Institut Bergonié, Bordeaux, France; Gynecology and Obstetrics Department, McGill University Health Centre, Montreal, Canada.
¹⁰ Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹¹ Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

PMID: 26683800
DOI: 10.1016/j.radonc.2015.11.013

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.

Keywords: Adjuvant; Consensus; Endometrial neoplasms; Practice guideline; Surgery; Treatment.

Publication types

Consensus Development Conference
Research Support, Non-U.S. Gov't

MeSH terms

Body Mass Index
Consensus
Endometrial Neoplasms / diagnosis
Endometrial Neoplasms / therapy*
Female
Follow-Up Studies
Humans
Italy
Medical Oncology / methods
Practice Guidelines as Topic